Cargando…

Interleukin-15 as a Biomarker Candidate of Rheumatoid Arthritis Development

There is a need for definite diagnosis of rheumatoid arthritis (RA) at its earliest stages of development in order to introduce early and effective treatment. Here we assessed whether serum interleukin-15 (IL-15) can serve as a new biomarker of RA development in patients with undifferentiated arthri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurowska, Weronika, Przygodzka, Malgorzata, Jakubaszek, Michal, Kwiatkowska, Brygida, Maslinski, Wlodzimierz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291073/ https://www.ncbi.nlm.nih.gov/pubmed/32455601 http://dx.doi.org/10.3390/jcm9051555

Ejemplares similares

Monocyte-related biomarkers of rheumatoid arthritis development in undifferentiated arthritis patients – a pilot study
por: Kurowska, Weronika, et al.
Publicado: (2018)

Color fraction as a useful method of imaging synovium vascularization in patients with high activity of rheumatoid arthritis
por: Jakubaszek, Michał, et al.
Publicado: (2020)

The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis
por: Kurowska, Weronika, et al.
Publicado: (2017)

Significance of bone marrow edema in pathogenesis of rheumatoid arthritis
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2013)

Antibodies to Citrullinated Proteins (ACPA) Associate with Markers of Osteoclast Activation and Bone Destruction in the Bone Marrow of Patients with Rheumatoid Arthritis
por: Kurowska, Weronika, et al.
Publicado: (2021)

Polymyositis and dermatomyositis as a risk of developing cancer
por: Jakubaszek, Michał, et al.
Publicado: (2015)

The pathogenesis of rheumatoid arthritis in radiological studies. Part I: Formation of inflammatory infiltrates within the synovial membrane
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2012)

IL-15 and its role in rheumatoid arthritis
por: Kurowska-Stolarska, M, et al.
Publicado: (2003)

Different expression of chemokines in rheumatoid arthritis and osteoarthritis bone marrow
por: Kuca-Warnawin, Ewa H., et al.
Publicado: (2016)

Cytokines and integrins related to inflammation of joint and gut in patients with spondyloarthritis and inflammatory bowel disease
por: Kontny, Ewa, et al.
Publicado: (2017)

Cartilage and bone damage in rheumatoid arthritis
por: Ostrowska, Monika, et al.
Publicado: (2018)

Indirect costs of rheumatoid arthritis
por: Raciborski, Filip, et al.
Publicado: (2015)

Rheumatoid arthritis bone marrow environment supports Th17 response
por: Kuca-Warnawin, Ewa, et al.
Publicado: (2017)

CD4(+)FOXP3(+) T Cells in Rheumatoid Arthritis Bone Marrow Are Partially Impaired
por: Massalska, Magdalena, et al.
Publicado: (2020)

Enthesopathies and enthesitis. Part 1. Etiopathogenesis
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2015)

Factors of depression among patients with rheumatoid arthritis
por: Kwiatkowska, Brygida, et al.
Publicado: (2018)

DNA Methylation as a Future Therapeutic and Diagnostic Target in Rheumatoid Arthritis
por: Ciechomska, Marzena, et al.
Publicado: (2019)

Sjögren’s syndrome: still not fully understood disease
por: Maślińska, Maria, et al.
Publicado: (2014)

Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19
por: Massalska, Magdalena, et al.
Publicado: (2020)

Circulating tumour necrosis factor-α bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response
por: Marotte, Hubert, et al.
Publicado: (2005)

Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity
por: Mielnik, Pawel, et al.
Publicado: (2010)

Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients
por: Ciechomska, Marzena, et al.
Publicado: (2018)

Enthesopathies and enthesitis. Part 2: Imaging studies
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2015)

Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment
por: Bonek, Krzysztof, et al.
Publicado: (2021)

New evidence for a role of bone marrow in the pathogenesis of rheumatoid arthritis
por: Kurowska, Weronika, et al.
Publicado: (2016)

Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
por: Bonek, Krzysztof, et al.
Publicado: (2022)

Role of inflammatory factors and adipose tissue in pathogenesis of rheumatoid arthritis and osteoarthritis. Part I: Rheumatoid adipose tissue
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2013)

Humoral and cellular immunogenicity of COVID-19 booster dose vaccination in inflammatory arthritis patients
por: Wroński, Jakub, et al.
Publicado: (2022)

The Kinetics of Humoral and Cellular Responses after the Booster Dose of COVID-19 Vaccine in Inflammatory Arthritis Patients
por: Wroński, Jakub, et al.
Publicado: (2023)

Distinct lymphocyte subpopulations in bone marrow from rheumatoid arthritis and osteoarthritis patients: a role for IL-15?
por: Maslinski, W, et al.
Publicado: (2004)

Monocyte alterations in rheumatoid arthritis are dominated by preterm release from bone marrow and prominent triggering in the joint
por: Smiljanovic, Biljana, et al.
Publicado: (2018)

Different Secretory Activity of Articular and Subcutaneous Adipose Tissues from Rheumatoid Arthritis and Osteoarthritis Patients
por: Plebańczyk, Magdalena, et al.
Publicado: (2018)

Proinflammatory Soluble Interleukin-15 Receptor Alpha Is Increased in Rheumatoid Arthritis
por: Machado Diaz, Ana Cecilia, et al.
Publicado: (2012)

The inhibitor of differentiation-2 promotes synovial fibroblast-dependent osteoclastogenesis in rheumatoid arthritis
por: Kurowska-Stolarska, M, et al.
Publicado: (2005)

Prevalence of psoriatic arthritis and costs generated by treatment of psoriatic arthritis patients in the public health system – the case of Poland
por: Raciborski, Filip, et al.
Publicado: (2016)

IgA immunoglobulin isotype of rheumatoid factor in primary Sjögren’s syndrome
por: Maślińska, Maria, et al.
Publicado: (2021)

Interleukin-6 and Interleukin-15 as Possible Biomarkers of the Risk of Autoimmune Diabetes Development
por: Siewko, Katarzyna, et al.
Publicado: (2019)

Interleukin-6 in Rheumatoid Arthritis
por: Pandolfi, Franco, et al.
Publicado: (2020)

Candidate targets for antibody therapy of rheumatoid arthritis: CD64 and IL-15
por: van de Winkel, J
Publicado: (2003)

Interleukin 6 and Rheumatoid Arthritis
por: Yoshida, Yuji, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_f1e8ip3qoudub030dme6ce1pp8